Showing 31 - 40 of 831
Thammasat, Novo Nordisk Partner to Advance Clinical Research
Published on 12/11/2025
» Thammasat University Hospital, the Faculty of Medicine, Thammasat University, and Novo Nordisk Pharma (Thailand) Ltd. have signed a Memorandum of Understanding (MOU) to expand clinical trials at the hospital, building on their previous collaboration to tackle Diabetes and Obesity. This new agreement aims to drive positive change in the management and treatment of cardio-metabolic diseases in Thailand.
Bangkok advances urban health agenda with landmark mou
Published on 12/11/2025
» A major step forward in Bangkok’s public health journey was marked by the signing of a Memorandum of Understanding (MOU) to establish “Bangkok, City for Better Health” — a collaborative initiative between the Bangkok Metropolitan Administration (BMA), the Royal Danish Embassy Bangkok, and Novo Nordisk Pharma Thailand Ltd. The ceremony, held at the Embassy of Denmark, also unveiled the “Childhood Obesity Curriculum”, a tangible outcome of the project’s early success.
Killer disease spike bodes ill for future, new national survey finds
News, Apinya Wipatayotin, Published on 09/11/2025
» Thailand is facing worsening public health trends that could fuel a surge in non-communicable diseases (NCDs) in coming years, says the latest National Health Examination Survey (NHES).
Denmark joins anti-urban obesity drive
News, Poramet Tangsathaporn, Published on 08/11/2025
» The Bangkok Metropolitan Administration (BMA), the Danish Embassy, and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding (MoU) to promote healthier urban lifestyles and combat obesity under the "Bangkok, City for Better Health" initiative.
Unlock and Rock: Empowering Haemophilia Families
Published on 24/10/2025
» In a continued effort to enhance healthcare awareness and support for rare diseases, Chonburi Hospital, in collaboration with Novo Nordisk Pharma (Thailand) Ltd. (“Novo Nordisk”), hosted the “Unlock and Rock Haemophilia” event. The initiative aimed to raise awareness and strengthen understanding of haemophilia among children, patients, and their families, while engaging the haemophilia community in Eastern Thailand through the Thai Hemophilia Patient Club.
Lifestyle medicine seeks to promote ‘graceful longevity’
Apinya Wipatayotin, Published on 21/10/2025
» Lifestyle medicine is a term that describes a holistic approach to achieving graceful longevity among senior citizens, according to Dr Kobkarn Chunhasawatdikul, director of Medpark Well-Healing in Bangkok.
Walking after a meal helps keep blood sugar in check
Life, Dr Eve Glazier & Dr Elizabeth Ko, Published on 21/10/2025
» Dear Doctors: My husband has prediabetes. I read that going for a walk after you eat can help your blood sugar, so I always do that. But my husband says when you sit down again, your blood sugar goes right back up, so what's the point? Is that true? I'm not giving up on him joining me.
Healthy ageing in Southeast Asia
News, Pattana Promphat & Tedros Adhanom Ghebreyesus, Published on 20/10/2025
» The Southeast Asia region is undergoing one of the most profound demographic shifts in its history. By 2050, the proportion of people aged 60 years and above will nearly double -- from 11.3% in 2024 to 20.9%. That means 441 million older people -- one in five people -- will call this region home. This transformation is both a triumph of public health and a test of our collective will and capacity to adapt.
Govt steps up plan to curb kidney disease
News, Apinya Wipatayotin, Published on 17/10/2025
» Public Health Minister Pattana Promphat has launched a campaign to promote free dialysis treatment while emphasising the importance of public education and lifestyle changes to prevent chronic kidney disease (CKD).
Early Detection Vital to Prevent Vision Loss
Published on 09/10/2025
» On the occasion of “World Sight Day,” a leading ophthalmologist is highlighting two major but often overlooked eye conditions: age-related macular degeneration (nAMD) and diabetic macular edema (DME). These conditions pose a serious risk to vision, particularly among individuals aged 50 and older and those living with diabetes. With new treatments that make care more convenient and less frequent, early diagnosis remains the best defence against preventable blindness.